ASCL2 and neoplasm: To our knowledge, our study is the only publication to date that demonstrates that the selective blockade of Ascl2 expression in HT-29 and LS174T cells results in tumor growth arrest both in vitro and in vivo, possibly through a miRNA-302b-related inhibition of colon cancer progenitor cells.